MWM
IBRX icon

MFG Wealth Management’s ImmunityBio IBRX Stock Holding History

MFG Wealth Management’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Sell
173,885
-1,465
-0.8% -$11.1K 1.09% 49
2026
Q1 		$1.34M Buy
+175,350
New +$1.2M 1.12% 48

Other funds holding IBRX

SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
DKCM
Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CFO
Collective Family Office York, Pennsylvania $489M AUM 21.64% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
CIC
Cutler Investment Counsel Jacksonville, Oregon $1.06B AUM 20.29% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

MFG Wealth Management's IBRX Position: Q2 2026 in Review

MFG Wealth Management reduced its ImmunityBio (IBRX) stake by 0.84% in Q2 2026, selling an estimated $11.1K and leaving 173,885 shares worth $1.52M. The position accounts for 1.09% of the portfolio, ranked #49.

MFG Wealth Management first reported a position in IBRX in Q1 2026 and has held it in 2 quarters since. 55 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • MFG Wealth Management held 173,885 shares of ImmunityBio worth $1.52M as of Q2 2026.
  • MFG Wealth Management sold 1,465 ImmunityBio shares in Q2 2026, an estimated $11.1K.
  • ImmunityBio made up 1.09% of MFG Wealth Management's portfolio in Q2 2026, its #49 holding.
  • MFG Wealth Management first reported a position in ImmunityBio in Q1 2026 and has held it in 2 quarters since.
  • 55 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on MFG Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.